13F Holdings
中文EN

CVS CVS HEALTH Corp

Retail-Drug Stores and Proprietary Stores · NYSE · SEC CIK 64803 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.7%
TTM net income YoY2,253.3%
TTM EPS YoY2,165.8%
Revenue 3-yr CAGR6.5%
Net income 3-yr CAGR8.5%

Margins

Gross margin44.2%
Operating margin3.6%
Net margin2.6%
FCF margin3.7%
EBITDA margin4.7%

Returns

ROE14.4%
ROA4.3%
ROIC (approx.)10.8%
Asset turnover1.64x

Leverage & solvency

Liabilities / assets68.7%
Debt / equity0.75x
Current ratio0.85x
Interest coverage4.91x

Cash quality & payout

Operating cash flow / net income1.70x
Accruals ratio-3.0%
Payout ratio31.0%
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$402.07B$372.81B$357.78B$322.47B$292.11B
Cost of revenue$221.17B$206.29B$217.10B$196.89B$175.80B
Gross profit$180.90B$166.52B$140.68B$125.58B$116.31B
Operating income$4.66B$8.52B$13.74B$7.95B$13.31B
Interest expense$3.12B$2.96B$2.66B$2.29B$2.50B
Pretax income$2.14B$6.15B$11.17B$5.84B$10.54B
Income tax$408.00M$1.56B$2.81B$1.51B$2.55B
Net income$1.77B$4.61B$8.34B$4.31B$8.00B
EBITDA$9.27B$13.11B$18.11B$12.18B$17.80B
EPS (basic)1.403.676.493.296.07
EPS (diluted)1.393.666.473.266.02
Dividends declared per share2.662.662.422.202.00
Weighted avg. shares (diluted)1.27B1.26B1.29B1.32B1.33B
Balance sheet
Cash & equivalents$8.45B$8.88B$8.20B$13.30B$12.69B
Short-term investments$2.15B$2.41B$3.26B$2.78B$3.12B
Receivables$39.78B$36.47B$35.23B$27.28B$24.43B
Inventory$19.25B$18.11B$18.02B$19.09B$17.76B
Current assets$74.71B$68.64B$67.86B$65.63B$60.01B
PP&E, net$13.08B$12.99B$13.18B$12.87B$12.90B
Goodwill$85.48B$91.27B$91.27B$78.15B$79.12B
Intangibles$25.51B$27.32B$29.23B$24.80B$29.03B
Total assets$253.54B$253.22B$249.73B$228.28B$233.00B
Current liabilities$88.69B$84.61B$79.19B$69.42B$67.81B
Short-term debt$4.07B$2.12B$200.00M$0$4.21B
Long-term debt$60.50B$60.53B$58.64B$50.48B$51.97B
Total debt$64.57B$62.65B$58.84B$50.48B$56.18B
Total liabilities$178.16B$177.49B$173.09B$156.51B$157.62B
Shareholders' equity$75.21B$75.56B$76.46B$71.47B$75.08B
Net debt$56.12B$53.76B$50.64B$37.17B$43.48B
Shares outstanding1.27B1.26B1.29B1.30B1.32B
Cash flow statement
Operating cash flow$10.64B$9.11B$13.43B$16.18B$18.27B
Capital expenditure$2.83B$2.78B$3.03B$2.73B$2.52B
Free cash flow$7.81B$6.33B$10.39B$13.45B$15.74B
Investing cash flow-$5.87B-$7.61B-$20.89B-$5.05B-$5.26B
Financing cash flow-$4.94B-$1.14B$2.68B-$10.52B-$11.36B
Depreciation & amortization$4.61B$4.60B$4.37B$4.22B$4.49B
Stock-based compensation$535.00M$540.00M$588.00M$447.00M$484.00M
Dividends paid$3.40B$3.37B$3.13B$2.91B$2.62B
Share buybacks$0$3.02B$2.01B$3.50B$0

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.